Stem Cell Transplantation May Aid Hard-to-Treat Scleroderma Patients
Results from a new study led by researchers at Geisel and presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, showed that stem cell transplantation was beneficial to scleroderma patients who don’t respond to current immunosuppressive therapies.
Source: News at Dartmouth Medical School - Category: Hospital Management Authors: Timothy Dean Tags: News Research autoimmune disease Michael Whitfield Scleroderma Source Type: news
More News: Autoimmune Disease | Hospital Management | Rheumatology | Scleroderma | Stem Cell Therapy | Stem Cells | Study | Transplants